FDA Expands Secukinumab Approval to Patients 12 Years and Older With Hidradenitis Suppurativa

News release. Novartis. March 13, 2026. Accessed March 16, 2026. https://www.novartis.com/news/media-releases/novartis-cosentyx-receives-fda …